Biomarkers in the diagnosis of pleural diseases: a 2018 update

Biomarkers in the diagnosis of pleural diseases: a 2018 update

The use of biomarkers on pleural fluid (PF) specimens may assist the decision-making process and enhance clinical diagnostic pathways. Three paradigmatic examples are heart failure, tuberculosis and, particularly, malignancy. An elevated PF concentration of the amino-terminal fragment of probrain na...

Full description

Bibliographic Details
Main Author:	José M. Porcel
Format:	Article
Language:	English
Published:	SAGE Publishing 2018-10-01
Series:	Therapeutic Advances in Respiratory Disease
Online Access:	https://doi.org/10.1177/1753466618808660

Similar Items

Diagnosis exjuvantibus of a persistent pleural effusion
by: José M. Porcel
Published: (2013-12-01)

Diagnóstico no invasivo del derrame pleural maligno Non-invasive diagnosis of malignant pleural effusion
by: José Manuel Porcel
Published: (2006-06-01)

Update on pleural diseases - 2007
by: Bishay Ayman, et al.
Published: (2007-01-01)

Biomarkers in routine diagnosis of pleural eﬀusions
by: Tiva Nemanič, et al.
Published: (2018-03-01)

Malignant pleural mesothelioma: an update on diagnosis and treatment options
by: Sanjana Kondola, et al.
Published: (2016-06-01)

Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment
by: Anna C. Bibby, et al.
Published: (2016-12-01)

Diagnosis of infectious pleural effusion using predictive models based on pleural fluid biomarkers
by: Lucía Ferreiro, et al.
Published: (2019-01-01)

Pleural Fluid GSDMD Is a Novel Biomarker for the Early Differential Diagnosis of Pleural Effusion
by: Pu Li, et al.
Published: (2021-06-01)

Efficacy of pleural brush cytology in the diagnosis of pleural diseases
by: Rakhee Sodhi Khanduri, et al.
Published: (2019-01-01)

Is pulmonary embolism associated with pleural transudates, exudates, or both?
by: José M. Porcel, et al.
Published: (2021-01-01)

Biomarkers for Early Diagnosis and Prognosis of Malignant Pleural Mesothelioma: The Quest Goes on
by: Caterina Ledda, et al.
Published: (2018-06-01)

Secreted and Tissue miRNAs as Diagnosis Biomarkers of Malignant Pleural Mesothelioma
by: Vanessa Martínez-Rivera, et al.
Published: (2018-02-01)

Ultrasound guided closed pleural biopsy versus medical thoracoscopic pleural biopsy in diagnosis of pleural diseases
by: K. Sobhy, et al.
Published: (2017-01-01)

Diving into the Pleural Fluid: Liquid Biopsy for Metastatic Malignant Pleural Effusions
by: Maria Alba Sorolla, et al.
Published: (2021-06-01)

New Updates of the Imaging Role in Diagnosis, Staging, and Response Treatment of Malignant Pleural Mesothelioma
by: Chiara Romei, et al.
Published: (2021-08-01)

Advances in the diagnosis of pleural disease in lung cancer
by: Kay Choong See, et al.
Published: (2011-12-01)

Role of sonography in diagnosis of pleural and lung diseases
by: Singh Sohan, et al.
Published: (2005-01-01)

Chinese Guidelines for the Diagnosis and Treatment of Urticaria: 2018 Update
by: Center for Urticaria Research, Chinese Society of Dermatology∗
Published: (2020-03-01)

Biomarkers in Glycogen Storage Diseases: An Update
by: Alberto Molares-Vila, et al.
Published: (2021-04-01)

Role of pleural biopsy in etiological diagnosis of pleural effusion
by: Pandit Sudipta, et al.
Published: (2010-01-01)

CT in differential diagnosis of benign and malignant pleural disease
by: U. Yilmaz, et al.
Published: (2005-03-01)

Pleural Fluid Mesothelin as an Adjunct to the Diagnosis of Pleural Malignant Mesothelioma
by: Jenette Creaney, et al.
Published: (2014-01-01)

Circulating biomarkers in malignant pleural mesothelioma
by: Giuseppe Viscardi, et al.
Published: (2020-12-01)

Accuracy of closed pleural biopsy in the diagnosis of malignant pleural effusion
by: Renata Báez-Saldaña, et al.

Value of thoracoscopic pleural brush in the diagnosis of exudative pleural effusion
by: Lamia H. Shaaban, et al.
Published: (2012-10-01)

Portuguese recommendations for the prevention, diagnosis and management of primary osteoporosis - 2018 update
by: A M Rodrigues, et al.
Published: (2018-01-01)

Pleural effusion: Role of pleural fluid cytology, adenosine deaminase level, and pleural biopsy in diagnosis
by: Biswajit Biswas, et al.
Published: (2016-01-01)

Recent Insights into the Management of Pleural Infection
by: Hassan M, et al.
Published: (2021-07-01)

Combined blood and pleural levels of mesothelin and osteopontin for the diagnosis of malignant pleural mesothelioma
by: Wafaa M. Ashour, et al.
Published: (2012-07-01)

Malignant pleural effusion: from bench to bedside
by: Ioannis Psallidas, et al.
Published: (2016-06-01)

Malignant Pleural Effusion: Diagnosis and Management
by: Lucía Ferreiro, et al.
Published: (2020-01-01)

A targeted proteomics pipeline reveals potential biomarkers for diagnosis of metastatic lung cancer in pleural effusion
by: Chi De Chen, et al.
Published: (2014)

Capabilities of Pleural Cavities Ultrasound Examination in Pleural Empyema Stage Diagnosis
by: V. I. Pertsov, et al.
Published: (2018-07-01)

Highly accurate diagnosis of pleural tuberculosis by immunological analysis of the pleural effusion.
by: Jayne S Sutherland, et al.
Published: (2012-01-01)

Fiberoptic Bronchoscopy in Diagnosis of Pleural Malignancy
by: M Solouki, et al.
Published: (2013-05-01)

Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma: 2018 update
by: Tae-Hyung Kim, et al.
Published: (2019-09-01)

Role of ultrasonography in the diagnosis of pleural effusion
by: Entsar S. Ahmed, et al.
Published: (2017-04-01)

New biomarkers in the selection of patients for talcage of pleural cavity in the palliative therapy of malign pleural exudate
by: Petr Habal, et al.
Published: (2015-12-01)

Novel biomarker analysis of pleural effusion enhances differentiation of tuberculous from malignant pleural effusion
by: Chen KY, et al.
Published: (2016-06-01)

Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
by: Marwan N. Sabbagh, et al.
Published: (2019-12-01)

Cannot write session to /tmp/vufind_sessions/sess_soei7u3a3geefcde454bs34csp